Evidence map›Paper›PMID 38109693›Full record

ArticleAnnals of the American Thoracic Society2024

Validation of Constant Work Rate Cycling Endurance Time for Use in Chronic Obstructive Pulmonary Disease Clinical Trials.

Richard Casaburi, Debora Merrill, Nancy Kline Leidy, Nicholas Locantore, Thomas Dolmage, Judith Garcia-Aymerich, Roger Goldstein, Gale Harding, François Maltais, Denis O'Donnell and 11 more

Abstract readValidation Study
PubMed Publisher
In one paragraph

Article in Annals of the American Thoracic Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 14 institutions in 5 countries.

Richard CasaburiRehabilitation Clinical Trials Center, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California.ORCID 0000-0002-8851-8589
Debora MerrillCOPD Foundation, Miami, Florida.
Nancy Kline LeidyEvidera, Bethesda, Maryland.
Nicholas LocantoreCOPD Foundation, Miami, Florida.
Thomas DolmageRespiratory Diagnostic & Evaluation Services and Respiratory Medicine, West Park Healthcare Centre, Toronto, Ontario, Canada.
Judith Garcia-AymerichISGlobal, Barcelona, Spain.
Roger GoldsteinDepartment of Medicine and Rehabilitation, University of Toronto, Toronto, Ontario, Canada.
Gale HardingEvidera, Bethesda, Maryland.
François MaltaisInstitut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Quebec City, Quebec, Canada.
Denis O'DonnellRespiratory Investigation Unit, Department of Medicine, Queen's University and Kingston Health Sciences Centre, Kingston, Ontario, Canada.
Janos PorszaszRehabilitation Clinical Trials Center, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California.
Luis Puente-MaestuHospital General Universitario Gregorio Marañón, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain.ORCID 0000-0001-8501-0117
Stephen RennardDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska.
Harry B RossiterRehabilitation Clinical Trials Center, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California.
Frank SciurbaDivision of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
Martijn A SpruitDepartment of Research & Development, CIRO, Horn, the Netherlands.
Ruth Tal-SingerTalSi Translational Medicine Consulting, LLC, Media, Pennsylvania.ORCID 0000-0002-5275-8062
Kay TetzlaffBoehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.
Alex Van't HulDepartment of Respiratory Diseases, Radboud Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.ORCID 0000-0002-5514-2327
Ren YuEvidera, Bethesda, Maryland.
Alan HamiltonCOPD Foundation, Miami, Florida.
COPD Foundation · USIthaka Harbors · USUCLA Medical Center · USBoehringer Ingelheim (Germany) · DEInstitut universitaire de cardiologie et de pneumologie de Québec · CAMaastricht University Medical Centre · NLQueen's University · CARadboud University Nijmegen · NLUniversidad Complutense de Madrid · ESUniversitat Pompeu Fabra · ESUniversity of Nebraska Medical Center · USUniversity of Pittsburgh · USUniversity of Toronto · CAWest Park Healthcare Centre · CA

Funding

AstraZenecaBoehringer IngelheimChiesi FarmaceuticiGlaxoSmithKlineMinisterio de Ciencia e Innovación CEX2018-000806-SNovartis
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bronchodilator AgentsPhysical EndurancePulmonary Disease, Chronic ObstructiveAgedClinical Trials as TopicExercise TestExercise TherapyExercise ToleranceFemaleForced Expiratory VolumeHumansMaleMiddle AgedReproducibility of ResultsBronchodilator Agentsbronchodilatorclinical outcome assessmentexercise enduranceexercise trainingpatient-centric

Identifiers

PMID38109693
OpenAlexW4389923156

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.